Glutamatergic agents show promise for mood and anxiety disorders

This press release is in support of a presentation by Professor Gerard Sanacora on Sunday 6 October at the 26th ECNP Congress in Barcelona, Spain. Depression is one of the leading causes of disability worldwide. New research suggests that targeting the glutamergic system may represent an exciting new avenue for treating mood and anxiety disorders.

Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...